SanguiBioTech GmbH focuses on the treatment of illnesses with an underlying acute or chronic oxygen deficiency. A new type of oxygen carrier based on natural hemoglobin was developed. SanguiBioTech's artificial oxygen carrier provides a range of cutting-edge applications with a very big market potential. It can be used for both blood loss as a substitute for conventional stored blood and, uniquely, as a blood additive for the treatment of circulatory disorders with a wide indication field.